metronidazole has been researched along with mercaptopurine in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (21.88) | 18.7374 |
| 1990's | 6 (18.75) | 18.2507 |
| 2000's | 9 (28.13) | 29.6817 |
| 2010's | 10 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Present, DH; Sachar, DB | 1 |
| Greseth, JL; Perrault, J; Tremaine, WJ | 1 |
| Cohen, SA; Daum, F; Glassman, M; Holmes, RD; Markowitz, J; Piccoli, D; Rossi, TM; Treem, WR; Ulshen, MH; Winter, HS | 1 |
| Lloyd-Still, JD | 1 |
| Riemann, JF | 1 |
| Greenberger, N | 1 |
| Korelitz, BI | 1 |
| Goldstein, F | 1 |
| Malchow, H | 1 |
| Gordon, PH; Stein, BL | 1 |
| van Hogezand, RA | 1 |
| Buffinton, GD; Doe, WF; McKenzie, SM | 1 |
| Arseneau, KO; Cohn, SM; Cominelli, F; Connors, AF | 1 |
| KRETTEK, JE | 1 |
| Herrlinger, K; Stange, EF | 1 |
| Boubaker, J; Filali, A; Kallel, L; Karoui, S | 1 |
| Assulin, Y; Beer-Gabel, M; Chowers, Y; Lahat, A | 1 |
| Hirata, Y; Joh, T; Kamiya, T; Kataoka, H; Mizoshita, T; Mizushima, T; Murakami, K; Ozeki, K; Shimura, T; Tanida, S; Tsukamoto, H | 1 |
| Andrews, JM; Bampton, PA; Bell, SJ; Brown, SJ; Connell, WR; De Cruz, P; Debinski, H; Desmond, PV; Elliott, PR; Florin, TH; Gearry, RB; Gibson, PR; Gorelik, A; Hamilton, AL; Johnston, MJ; Kamm, MA; Krejany, EO; Kronborg, I; Lawrance, IC; Leong, RW; Liew, D; Macrae, FA; Prideaux, L; Radford-Smith, G; Ritchie, KJ; Selby, W; Sparrow, M; Woods, R | 1 |
| Andrews, JM; Bampton, PA; Bell, SJ; Brown, SJ; Connell, WR; De Cruz, P; Debinski, H; Desmond, PV; Elliott, PR; Florin, TH; Gearry, RB; Gibson, PR; Gorelik, A; Hamilton, AL; Jakobovits, S; Johnston, MJ; Kamm, MA; Krejany, EO; Kronborg, I; Lawrance, IC; Leong, RW; Liew, D; Macrae, FA; Prideaux, L; Radford-Smith, G; Ritchie, KJ; Selby, W; Woods, R | 1 |
7 review(s) available for metronidazole and mercaptopurine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Immunotherapy in inflammatory bowel disease.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cromolyn Sodium; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Metronidazole | 1978 |
Regional enteritis.
Topics: Adolescent; Adult; Azathioprine; Crohn Disease; Diagnosis, Differential; Humans; Intestinal Absorption; Male; Mercaptopurine; Metronidazole; Parenteral Nutrition, Total; Prednisone; Sulfasalazine; Water-Electrolyte Balance | 1985 |
Perianal inflammatory conditions in inflammatory bowel disease.
Topics: Abscess; Adult; Colitis, Ulcerative; Combined Modality Therapy; Crohn Disease; Female; Humans; Male; Mercaptopurine; Metronidazole; Proctitis; Rectal Fistula; Rectovaginal Fistula | 1993 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole | 1994 |
[Chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Metronidazole; Pouchitis; Remission Induction; Tacrolimus; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2004 |
[Postoperative recurrence in Crohn's disease. Risk factors and methods of prevention].
Topics: Algorithms; Anastomosis, Surgical; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colon; Crohn Disease; Endoscopy; Female; Humans; Ileum; Immunosuppressive Agents; Male; Mercaptopurine; Mesalamine; Metronidazole; Odds Ratio; Randomized Controlled Trials as Topic; Risk; Risk Factors; Secondary Prevention; Smoking; Time Factors | 2006 |
4 trial(s) available for metronidazole and mercaptopurine
| Article | Year |
|---|---|
Immunotherapy in inflammatory bowel disease.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cromolyn Sodium; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Metronidazole | 1978 |
Azathioprine and the treatment of chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Metronidazole | 1990 |
Crohn's disease management after intestinal resection: a randomised trial.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Colonoscopy; Crohn Disease; Female; Humans; Male; Mercaptopurine; Metronidazole; Middle Aged; Recurrence; Treatment Outcome | 2015 |
Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis.
Topics: Adalimumab; Adult; Aged; Azathioprine; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Metronidazole; Middle Aged; Postoperative Period; Recurrence; Risk Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
22 other study(ies) available for metronidazole and mercaptopurine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
6-mercaptopurine therapy in selected cases of corticosteroid-dependent Crohn's disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Colonic Diseases; Crohn Disease; Female; Follow-Up Studies; Humans; Intestine, Small; Male; Mercaptopurine; Metronidazole; Middle Aged; Remission Induction; Retrospective Studies; Sulfasalazine; Time Factors | 1991 |
Immunology of inflammatory bowel disease: summary of the proceedings of the Subcommittee on Immunosuppressive Use in IBD.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Lipoxygenase Inhibitors; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole; Steroids | 1991 |
[Therapy of Crohn disease].
Topics: Aminosalicylic Acids; Azathioprine; Colectomy; Crohn Disease; Diet; Glucocorticoids; Humans; Mercaptopurine; Metronidazole; Psychotherapy; Sulfasalazine | 1989 |
Pregnancy, fertility, and inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Fetal Diseases; Humans; Infertility, Female; Infertility, Male; Male; Mercaptopurine; Metronidazole; Pregnancy; Pregnancy Complications; Risk; Sulfasalazine | 1985 |
Current status of medical treatment for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Mercaptopurine; Metronidazole; Parenteral Nutrition, Total; Sulfasalazine | 1983 |
[Therapy of chronic inflammatory bowel diseases].
Topics: Acute Disease; Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Mercaptopurine; Methylprednisolone; Metronidazole; Parenteral Nutrition; Sulfasalazine | 1983 |
5-aminosalicylic acid prevents oxidant mediated damage of glyceraldehyde-3-phosphate dehydrogenase in colon epithelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Colon; Dose-Response Relationship, Drug; Epithelial Cells; Free Radical Scavengers; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hypochlorous Acid; Mercaptopurine; Mesalamine; Methylprednisolone; Metronidazole; Oxidants; Oxidative Stress | 1999 |
Cost-utility of initial medical management for Crohn's disease perianal fistulae.
Topics: Adult; Antibodies, Monoclonal; Crohn Disease; Drug Costs; Drug Therapy, Combination; Female; Gastrointestinal Agents; Health Care Costs; Humans; Infliximab; Male; Mercaptopurine; Metronidazole; Middle Aged; Rectal Fistula | 2001 |
Experience with metronidazole, a new trichomonacide.
Topics: Female; Humans; Mercaptopurine; Metronidazole; Trichomonas Infections | 1962 |
Endoscopic ultrasound for perianal Crohn's disease: disease and fistula characteristics, and impact on therapy.
Topics: Abscess; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Anus Diseases; Azathioprine; Ciprofloxacin; Crohn Disease; Cutaneous Fistula; Endosonography; Female; Humans; Immunosuppressive Agents; Incidental Findings; Infliximab; Male; Mercaptopurine; Mesalamine; Metronidazole; Middle Aged; Rectal Fistula; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult | 2012 |
Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.
Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Colonoscopy; Combined Modality Therapy; Crohn Disease; Granulocytes; Humans; Immunosuppressive Agents; Leukapheresis; Leukocyte Reduction Procedures; Male; Mercaptopurine; Mesalamine; Metronidazole; Monocytes; Parenteral Nutrition, Total; Prednisolone; Remission Induction; Young Adult | 2012 |